CI
CL icon

Cigna Investments’s Colgate-Palmolive CL Stock Holding History

Cigna Investments’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$684K Sell
7,462
-123
-2% -$10.8K 0.09% 191
2026
Q1 		$647K Sell
7,585
-115
-1% -$10.2K 0.1% 191
2025
Q4 		$608K Hold
7,700
– – 0.09% 199
2025
Q3 		$615K Sell
7,700
-96
-1% -$8.19K 0.09% 196
2025
Q2 		$709K Sell
7,796
-307
-4% -$28K 0.12% 170
2025
Q1 		$759K Sell
8,103
-122
-1% -$10.9K 0.14% 151
2024
Q4 		$748K Sell
8,225
-72
-0.9% -$6.87K 0.13% 157
2024
Q3 		$861K Sell
8,297
-127
-2% -$12.9K 0.15% 135
2024
Q2 		$818K Sell
8,424
-162
-2% -$14.9K 0.15% 132
2024
Q1 		$773K Sell
8,586
-67
-0.8% -$5.68K 0.15% 143
2023
Q4 		$690K Sell
8,653
-36
-0.4% -$2.71K 0.14% 146
2023
Q3 		$618K Sell
8,689
-1,245
-13% -$93.1K 0.14% 151
2023
Q2 		$765K Sell
9,934
-47
-0.5% -$3.64K 0.14% 145
2023
Q1 		$750K Sell
9,981
-152
-2% -$11.3K 0.15% 140
2022
Q4 		$799K Buy
10,133
+67
+0.7% +$5.02K 0.17% 129
2022
Q3 		$708K Sell
10,066
-526
-5% -$41.2K 0.16% 134
2022
Q2 		$848K Sell
10,592
-4,042
-28% -$316K 0.17% 126
2022
Q1 		$1.11M Sell
14,634
-4,173
-22% -$331K 0.14% 145
2021
Q4 		$1.6M Sell
18,807
-6,975
-27% -$545K 0.13% 132
2021
Q3 		$1.95M Sell
25,782
-425
-2% -$33.7K 0.15% 129
2021
Q2 		$2.13M Sell
26,207
-4,209
-14% -$344K 0.15% 124
2021
Q1 		$2.4M Buy
30,416
+780
+3% +$61.1K 0.16% 120
2020
Q4 		$2.53M Buy
29,636
+2,120
+8% +$175K 0.2% 101
2020
Q3 		$2.12M Sell
27,516
-5,526
-17% -$421K 0.2% 100
2020
Q2 		$2.42M Sell
33,042
-6,754
-17% -$480K 0.23% 85
2020
Q1 		$2.64M Buy
39,796
+1,450
+4% +$102K 0.34% 64
2019
Q4 		$2.83M Sell
38,346
-7,285
-16% -$497K 0.3% 69
2019
Q3 		$3.13M Buy
45,631
+7,555
+20% +$548K 0.32% 66
2019
Q2 		$2.73M Buy
38,076
+13,424
+54% +$953K 0.3% 67
2019
Q1 		$1.69M Sell
24,652
-507
-2% -$32.7K 0.19% 115
2018
Q4 		$1.5M Buy
25,159
+106
+0.4% +$6.63K 0.13% 110
2018
Q3 		$1.49M Sell
25,053
-2,475
-9% -$165K 0.12% 129
2018
Q2 		$1.78M Sell
27,528
-4,327
-14% -$283K 0.13% 118
2018
Q1 		$2.28M Sell
31,855
-164
-0.5% -$11.8K 0.15% 94
2017
Q4 		$2.42M Sell
32,019
-1,385
-4% -$101K 0.16% 89
2017
Q3 		$2.43M Sell
33,404
-320
-0.9% -$23.1K 0.16% 88
2017
Q2 		$2.5M Sell
33,724
-27,148
-45% -$2.02M 0.17% 87
2017
Q1 		$4.46M Buy
60,872
+3,652
+6% +$256K 0.31% 43
2016
Q4 		$3.74M Buy
+57,220
New +$3.92M 0.41% 43

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Cigna Investments's CL Position: Q2 2026 in Review

Cigna Investments reduced its Colgate-Palmolive (CL) stake by 1.6% in Q2 2026, selling an estimated $10.8K and leaving 7,462 shares worth $684K. The position accounts for 0.09% of the portfolio, ranked #191.

Cigna Investments first reported a position in CL in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.46M in Q1 2017. 600 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cigna Investments held 7,462 shares of Colgate-Palmolive worth $684K as of Q2 2026.
  • Cigna Investments sold 123 Colgate-Palmolive shares in Q2 2026, an estimated $10.8K.
  • Colgate-Palmolive made up 0.09% of Cigna Investments's portfolio in Q2 2026, its #191 holding.
  • Cigna Investments first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 39 quarters since.
  • Cigna Investments's Colgate-Palmolive position peaked at $4.46M in Q1 2017.
  • 600 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.